
Cardinal Health, Inc. (CAH)
$
214.88
+3.65 (1.70%)
Key metrics
Financial statements
Free cash flow per share
18.7059
Market cap
51.1 Billion
Price to sales ratio
0.2179
Debt to equity
-3.1372
Current ratio
0.9570
Income quality
3.1239
Average inventory
17.2 Billion
ROE
-0.5500
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Cardinal Health, Inc. operates as an integrated healthcare services and products company providing customized solutions across the United States, Canada, Europe, Asia, and other international markets. The company offers tailored services to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home care patients. The company functions in two primary segments: Pharmaceutical and Medical. The Pharmaceutical segment is responsible for distributing both branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products. Additionally, it supports pharmaceutical manufacturers and healthcare providers through various services linked to specialty pharmaceuticals; manages nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic and over-the-counter healthcare products; and delivers medication therapy management and patient outcomes services to hospitals, healthcare providers, and payers. The operational income ratio is 0.01 indicating the company's operational profitability margin, while the company recorded an operating income of $2,275,000,000.00 reflecting its earnings from core operations. The income before tax ratio stands at 0.01 which shows the pre-tax margin. On the stock market, the company’s stock is identified with the symbol 'CAH', and the gross profit is $8,168,000,000.00 highlighting the company's profitability from its core operations. Conversely, the Medical segment involves the manufacture, sourcing, and distribution of Cardinal Health branded medical, surgical, and laboratory products, along with a comprehensive range of solutions for healthcare providers. The stock is reasonably priced at $149.60 appealing to a broad array of investors. With a high average trading volume of 2,122,326.00 it demonstrates strong liquidity in the market. The company boasts a mid-range market capitalization of $51,054,422,625.00 positioning it as a steady performer within the industry. As a key player in the Medical - Distribution industry, Cardinal Health significantly contributes to the overall market landscape and embraces its role in driving innovation and growth as part of the Healthcare sector. The combination of a robust product portfolio, strategic market presence, and solid financial metrics underlines the company's commitment to delivering effective healthcare solutions.
Investing in Cardinal Health, Inc. (CAH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Cardinal Health, Inc. stock to fluctuate between $120.72 (low) and $216.51 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-01-30, Cardinal Health, Inc.'s market cap is $51,054,422,625, based on 237,595,042 outstanding shares.
Compared to Eli Lilly & Co., Cardinal Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
Cardinal Health, Inc. pays dividends. The current dividend yield is 0.99%, with a payout of $0.51 per share.
To buy Cardinal Health, Inc. (CAH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CAH. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Cardinal Health, Inc.'s last stock split was 3:2 on 2001-04-23.
Revenue: $222,578,000,000 | EPS: $6.48 | Growth: 86.21%.
Visit https://www.cardinalhealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $216.51 (2026-01-29) | All-time low: $45.85 (2021-12-01).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com
Cardinal Health (CAH) reached $210.93 at the closing of the latest trading day, reflecting a +1.25% change compared to its last close.

zacks.com
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

seekingalpha.com
Cardinal Health gets upgraded to a buy, despite its price having gone up over 100% since my bullish call in early 2024. CAH could benefit from longer-term macro demand for medical supplies, mitigating near-term provider margin pressures. Recent growth drivers include positive FY26 guidance, the Solaris Health acquisition, innovative product launches, and advances in nuclear medicine mentioned in the article.

zacks.com
Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

zacks.com
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

zacks.com
In the latest trading session, Cardinal Health (CAH) closed at $208.26, marking a +2.83% move from the previous day.

seekingalpha.com
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
barrons.com
The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.
See all news